Literature DB >> 34089016

Six months of COVID vaccines: what 1.7 billion doses have taught scientists.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Epidemiology; Infection; SARS-CoV-2; Vaccines

Year:  2021        PMID： 34089016     DOI： 10.1038/d41586-021-01505-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

Authors:  Shabir A Madhi; Vicky Baillie; Clare L Cutland; Merryn Voysey; Anthonet L Koen; Lee Fairlie; Sherman D Padayachee; Keertan Dheda; Shaun L Barnabas; Qasim E Bhorat; Carmen Briner; Gaurav Kwatra; Khatija Ahmed; Parvinder Aley; Sutika Bhikha; Jinal N Bhiman; As'ad E Bhorat; Jeanine du Plessis; Aliasgar Esmail; Marisa Groenewald; Elizea Horne; Shi-Hsia Hwa; Aylin Jose; Teresa Lambe; Matt Laubscher; Mookho Malahleha; Masebole Masenya; Mduduzi Masilela; Shakeel McKenzie; Kgaogelo Molapo; Andrew Moultrie; Suzette Oelofse; Faeezah Patel; Sureshnee Pillay; Sarah Rhead; Hylton Rodel; Lindie Rossouw; Carol Taoushanis; Houriiyah Tegally; Asha Thombrayil; Samuel van Eck; Constantinos K Wibmer; Nicholas M Durham; Elizabeth J Kelly; Tonya L Villafana; Sarah Gilbert; Andrew J Pollard; Tulio de Oliveira; Penny L Moore; Alex Sigal; Alane Izu
Journal:  N Engl J Med       Date:  2021-03-16       Impact factor: 91.245

2.  Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.

Authors:  Matan Levine-Tiefenbrun; Idan Yelin; Rachel Katz; Esma Herzel; Ziv Golan; Licita Schreiber; Tamar Wolf; Varda Nadler; Amir Ben-Tov; Jacob Kuint; Sivan Gazit; Tal Patalon; Gabriel Chodick; Roy Kishony
Journal:  Nat Med       Date:  2021-03-29       Impact factor: 53.440

3.  Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Adeel A Butt
Journal:  N Engl J Med       Date:  2021-05-05       Impact factor: 91.245

4.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

Authors:  David S Khoury; Deborah Cromer; Arnold Reynaldi; Timothy E Schlub; Adam K Wheatley; Jennifer A Juno; Kanta Subbarao; Stephen J Kent; James A Triccas; Miles P Davenport
Journal:  Nat Med       Date:  2021-05-17       Impact factor: 87.241

5.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

6.  SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

Authors:  Victoria Jane Hall; Sarah Foulkes; Andre Charlett; Ana Atti; Edward J M Monk; Ruth Simmons; Edgar Wellington; Michelle J Cole; Ayoub Saei; Blanche Oguti; Katie Munro; Sarah Wallace; Peter D Kirwan; Madhumita Shrotri; Amoolya Vusirikala; Sakib Rokadiya; Meaghan Kall; Maria Zambon; Mary Ramsay; Tim Brooks; Colin S Brown; Meera A Chand; Susan Hopkins
Journal:  Lancet       Date:  2021-04-09       Impact factor: 79.321

7.  Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.

Authors:  Eric J Haas; Frederick J Angulo; John M McLaughlin; Emilia Anis; Shepherd R Singer; Farid Khan; Nati Brooks; Meir Smaja; Gabriel Mircus; Kaijie Pan; Jo Southern; David L Swerdlow; Luis Jodar; Yeheskel Levy; Sharon Alroy-Preis
Journal:  Lancet       Date:  2021-05-05       Impact factor: 79.321

8.  Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.

Authors:  Vivek Shinde; Sutika Bhikha; Zaheer Hoosain; Moherndran Archary; Qasim Bhorat; Lee Fairlie; Umesh Lalloo; Mduduzi S L Masilela; Dhayendre Moodley; Sherika Hanley; Leon Fouche; Cheryl Louw; Michele Tameris; Nishanta Singh; Ameena Goga; Keertan Dheda; Coert Grobbelaar; Gertruida Kruger; Nazira Carrim-Ganey; Vicky Baillie; Tulio de Oliveira; Anthonet Lombard Koen; Johan J Lombaard; Rosie Mngqibisa; As'ad E Bhorat; Gabriella Benadé; Natasha Lalloo; Annah Pitsi; Pieter-Louis Vollgraaff; Angelique Luabeya; Aliasgar Esmail; Friedrich G Petrick; Aylin Oommen-Jose; Sharne Foulkes; Khatija Ahmed; Asha Thombrayil; Lou Fries; Shane Cloney-Clark; Mingzhu Zhu; Chijioke Bennett; Gary Albert; Emmanuel Faust; Joyce S Plested; Andreana Robertson; Susan Neal; Iksung Cho; Greg M Glenn; Filip Dubovsky; Shabir A Madhi
Journal:  N Engl J Med       Date:  2021-05-05       Impact factor: 91.245

9.  Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

Authors:  Jerald Sadoff; Glenda Gray; An Vandebosch; Vicky Cárdenas; Georgi Shukarev; Beatriz Grinsztejn; Paul A Goepfert; Carla Truyers; Hein Fennema; Bart Spiessens; Kim Offergeld; Gert Scheper; Kimberly L Taylor; Merlin L Robb; John Treanor; Dan H Barouch; Jeffrey Stoddard; Martin F Ryser; Mary A Marovich; Kathleen M Neuzil; Lawrence Corey; Nancy Cauwenberghs; Tamzin Tanner; Karin Hardt; Javier Ruiz-Guiñazú; Mathieu Le Gars; Hanneke Schuitemaker; Johan Van Hoof; Frank Struyf; Macaya Douoguih
Journal:  N Engl J Med       Date:  2021-04-21       Impact factor: 176.079

10.  Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

Authors:  Robert W Frenck; Nicola P Klein; Nicholas Kitchin; Alejandra Gurtman; Judith Absalon; Stephen Lockhart; John L Perez; Emmanuel B Walter; Shelly Senders; Ruth Bailey; Kena A Swanson; Hua Ma; Xia Xu; Kenneth Koury; Warren V Kalina; David Cooper; Timothy Jennings; Donald M Brandon; Stephen J Thomas; Özlem Türeci; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2021-05-27       Impact factor: 91.245
  10 in total
  21 in total

1.  Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.

Authors:  Hardik Goswami; Adnan Alsumali; Yiling Jiang; Matthias Schindler; Elizabeth R Duke; Joshua Cohen; Andrew Briggs; Amy Puenpatom
Journal:  Pharmacoeconomics       Date:  2022-07-02       Impact factor: 4.558

Review 2.  Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021.

Authors:  Chang-Jie Cheng; Chun-Yi Lu; Ya-Hui Chang; Yu Sun; Hai-Jui Chu; Chun-Yu Lee; Chang-Hsiu Liu; Cheng-Huai Lin; Chien-Jung Lu; Chung-Yi Li
Journal:  Vaccines (Basel)       Date:  2021-12-16

3.  Incidence of COVID-19 reinfection among Midwestern healthcare employees.

Authors:  Anne Rivelli; Veronica Fitzpatrick; Christopher Blair; Kenneth Copeland; Jon Richards
Journal:  PLoS One       Date:  2022-01-04       Impact factor: 3.240

4.  An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.

Authors:  Peter A van der Ley; Afshin Zariri; Elly van Riet; Dinja Oosterhoff; Corine P Kruiswijk
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

5.  A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.

Authors:  Yot Teerawattananon; Thunyarat Anothaisintawee; Chatkamol Pheerapanyawaranun; Siobhan Botwright; Katika Akksilp; Natchalaikorn Sirichumroonwit; Nuttakarn Budtarad; Wanrudee Isaranuwatchai
Journal:  PLoS One       Date:  2022-01-11       Impact factor: 3.240

6.  [Vaccination willingness against COVID-19 among healthcare workers in Germany : Results from a University Medicine Network survey between November 2020 and January 2021].

Authors:  Caterina Schug; Yesim Erim; Franziska Geiser; Nina Hiebel; Petra Beschoner; Lucia Jerg-Bretzke; Christian Albus; Kerstin Weidner; Susann Steudte-Schmiedgen; Andrea Borho; Marietta Lieb; Eva Morawa
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-09-23       Impact factor: 1.513

7.  Optimized Post-Vaccination Strategies and Preventative Measures for SARS-CoV-2.

Authors:  Rowland Pettit; Bo Peng; Patrick Yu; Peter G Matos; Alexander L Greninger; Julie McCashin; Christopher Ian Amos
Journal:  medRxiv       Date:  2021-09-21

8.  Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors.

Authors:  Julia K Stille; Jevgenijs Tjutrins; Guanyu Wang; Felipe A Venegas; Christopher Hennecker; Andrés M Rueda; Itai Sharon; Nicole Blaine; Caitlin E Miron; Sharon Pinus; Anne Labarre; Jessica Plescia; Mihai Burai Patrascu; Xiaocong Zhang; Alexander S Wahba; Danielle Vlaho; Mitchell J Huot; T Martin Schmeing; Anthony K Mittermaier; Nicolas Moitessier
Journal:  Eur J Med Chem       Date:  2021-12-11       Impact factor: 6.514

9.  Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.

Authors:  Archana Asundi; Colin O'Leary; Nahid Bhadelia
Journal:  Cell Host Microbe       Date:  2021-07-14       Impact factor: 21.023

Review 10.  Potential metal-related strategies for prevention and treatment of COVID-19.

Authors:  Ya-Qiong Ni; Hui-Hui Zeng; Xian-Wen Song; Jun Zheng; Hui-Qiong Wu; Chun-Tai Liu; Yi Zhang
Journal:  Rare Metals       Date:  2022-01-17       Impact factor: 6.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.